Literature DB >> 17694326

Activation of subventricular zone stem cells after neuronal injury.

Yongsoo Kim1, Francis G Szele.   

Abstract

The mammalian subventricular zone (SVZ) has garnered a tremendous amount of attention as a potential source of replacement cells for neuronal injury. This zone is highly neurogenic, harbours stem cells and supports long-distance migration. The general pattern of activation includes increased proliferation, neurogenesis and emigration towards the injury. Intrinsic transcription factors and environmental signalling molecules are rapidly being discovered that may facilitate the induction of these cells to mount appropriate therapeutic responses. The extent of SVZ neurogenesis in humans is controversial. However, tantalizing new data suggest that humans are capable of generating increased numbers of neurons after a variety of diseases.

Entities:  

Mesh:

Year:  2007        PMID: 17694326     DOI: 10.1007/s00441-007-0451-1

Source DB:  PubMed          Journal:  Cell Tissue Res        ISSN: 0302-766X            Impact factor:   5.249


  11 in total

1.  Neurogenesis is required for behavioral recovery after injury in the visual system of Xenopus laevis.

Authors:  Caroline R McKeown; Pranav Sharma; Heidi E Sharipov; Wanhua Shen; Hollis T Cline
Journal:  J Comp Neurol       Date:  2013-07-01       Impact factor: 3.215

Review 2.  Engineering therapies in the CNS: what works and what can be translated.

Authors:  Andrew J Shoffstall; Dawn M Taylor; Erin B Lavik
Journal:  Neurosci Lett       Date:  2012-02-04       Impact factor: 3.046

3.  Pharmacogenomic identification of small molecules for lineage specific manipulation of subventricular zone germinal activity.

Authors:  Kasum Azim; Diane Angonin; Guillaume Marcy; Francesca Pieropan; Andrea Rivera; Vanessa Donega; Claudio Cantù; Gareth Williams; Benedikt Berninger; Arthur M Butt; Olivier Raineteau
Journal:  PLoS Biol       Date:  2017-03-28       Impact factor: 8.029

4.  Interplay of hormones and p53 in modulating gender dimorphism of subventricular zone cell number.

Authors:  Jin Young Kim; Patrizia Casaccia-Bonnefil
Journal:  J Neurosci Res       Date:  2009-11-15       Impact factor: 4.164

5.  Histological and ultrastructural comparison of cauterization and thrombosis stroke models in immune-deficient mice.

Authors:  Silvia Mora-Lee; Ma Salomé Sirerol-Piquer; María Gutiérrez-Pérez; Tania López; Mayte Casado-Nieto; Carlos Jauquicoam; Gloria Abizanda; Miriam Romaguera-Ros; Ulises Gomez-Pinedo; Felipe Prósper; José-Manuel García-Verdugo
Journal:  J Inflamm (Lond)       Date:  2011-10-18       Impact factor: 4.981

6.  Fluvoxamine stimulates oligodendrogenesis of cultured neural stem cells and attenuates inflammation and demyelination in an animal model of multiple sclerosis.

Authors:  Majid Ghareghani; Kazem Zibara; Heibatollah Sadeghi; Shima Dokoohaki; Hossein Sadeghi; Roya Aryanpour; Amir Ghanbari
Journal:  Sci Rep       Date:  2017-07-07       Impact factor: 4.379

7.  Promoting in vivo remyelination with small molecules: a neuroreparative pharmacological treatment for Multiple Sclerosis.

Authors:  Eva María Medina-Rodríguez; Ana Bribián; Amanda Boyd; Valle Palomo; Jesús Pastor; Alfonso Lagares; Carmen Gil; Ana Martínez; Anna Williams; Fernando de Castro
Journal:  Sci Rep       Date:  2017-03-03       Impact factor: 4.379

8.  Role of phosphodiesterase 5 in synaptic plasticity and memory.

Authors:  Daniela Puzzo; Salvatore Sapienza; Ottavio Arancio; Agostino Palmeri
Journal:  Neuropsychiatr Dis Treat       Date:  2008-04       Impact factor: 2.570

Review 9.  Regeneration, Plasticity, and Induced Molecular Programs in Adult Zebrafish Brain.

Authors:  Mehmet Ilyas Cosacak; Christos Papadimitriou; Caghan Kizil
Journal:  Biomed Res Int       Date:  2015-08-31       Impact factor: 3.411

10.  Nucleofection of rodent neuroblasts to study neuroblast migration in vitro.

Authors:  Katarzyna Falenta; Sangeetha Gajendra; Martina Sonego; Patrick Doherty; Giovanna Lalli
Journal:  J Vis Exp       Date:  2013-11-12       Impact factor: 1.355

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.